Evidence map›Paper›PMID 40973140›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

A Preliminary Prospective Study on the Association of Polymorphisms in

John Prenzler, Alison Haywood, Heidi Sutherland G, Omar Ibrahim, Matthew Zunk, Sudeep Bista R, Phillip Good, Lyn Griffiths R, Janet Hardy, Larisa M Haupt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

John PrenzlerSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
Alison HaywoodSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.ORCID 0000-0002-5354-8868
Heidi Sutherland GCentre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Omar IbrahimCentre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Matthew ZunkSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
Sudeep Bista RSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
Phillip GoodMater Research Institute, University of Queensland, Brisbane, QLD, Australia.
Lyn Griffiths RCentre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Janet HardyMater Research Institute, University of Queensland, Brisbane, QLD, Australia.
Larisa M HauptCentre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.ORCID 0000-0002-7735-8110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionPain is common in cancer patients, particularly in the advanced stage of the disease with more than 70% prevalence. Despite research regarding cancer pain management, clinicians' ability to predict and manage patient pain remains a significant challenge.Patients and MethodsThis sub-study of a prospective, open label, dose individualization study, investigated how selected single nucleotide polymorphisms (SNPs) in the

Indexed as

beta-Arrestin 2Brain-Derived Neurotrophic FactorCancer PainFentanylG Protein-Coupled Inwardly-Rectifying Potassium ChannelsPain ManagementAgedAged, 80 and overAnalgesics, OpioidFemaleGenotypeHumansMaleMiddle AgedNeoplasmsPolymorphism, Single NucleotideAnalgesics, OpioidARRB2 protein, humanBDNF protein, humanbeta-Arrestin 2Brain-Derived Neurotrophic FactorFentanylG Protein-Coupled Inwardly-Rectifying Potassium ChannelsKCNJ6 protein, humanARRB2BDNFfentanylKCNJ6opioidspalliative care

Identifiers

PMID40973140
PMCPMC12449645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.